🌐 AbCellera
AbCellera is a biotechnology company specializing in the rapid discovery and development of antibody therapies through AI-driven single-cell analysis.
7
Signals
5
Articles
Linked Signals
| Signal | Status | Lens | Role | Confidence | Last Seen |
|---|---|---|---|---|---|
| ‘Astonishing’: Music therapy ignites compensatory brain wiring in dementia | active | Health | involved | 100% | |
| AbCellera Has Promising Menopause Data, But Much Of The Opportunity Is Priced In | expired | Health | involved | 48% | |
| Coinmico Launches Crypto Market Data Platform Built From Observed Trading Activity | expired | AI & Tech | involved | 86% | |
| Sempra Infrastructure signs 20-year LNG deal with Petrobras | expired | Deals | involved | 100% | |
| AbCellera and Recursion Pharmaceuticals: two AI-drug stocks, two different stories | expired | Health | involved | 40% | |
| France coach Deschamps fears player burn-out at expanded World Cup | expired | Health | responder | 100% | |
| CLO ETFs Boom on Higher Rates, Private Debt Woes | expired | Deals | involved | 100% |